BD Announces Intent to Separate Biosciences and Diagnostic Solutions Business to Enhance Focus, Drive Growth and Unlock Value
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced its board of directors has unanimously authorized BD management to pursue a plan to separate BD's Biosciences and Diagnostic Solutions business from the rest of BD to enhance strategic focus and growth-oriented investments and capital allocation for both BD and the separated business and enhance value creation for shareholders.
Today's medical AI systems represent not just a new diagnostic tool, but a new kind of medical reasoning altogether, writes ...
Femasys has gained approval for its FemaSeed Intratubal Insemination product and two diagnostic devices from the Ministry of ...
PPC Healthcare, a leading healthcare solutions provider, has urged Nigerians to embrace routine cancer screening to increase ...
and his goals to normalize this diagnostic technology in the medical industry. Learn more about Vitazi.ai here. About New Mexico Frontiers Digital Show New Mexico Frontiers Digital Show is KRQE ...
We then highlight some newer diagnostic technology, which, although yet unproven, shows promise in improving diagnosis and early detection of breast cancer for the near future. Mammography is ...
In this rapidly growing digital world, groundbreaking research published in the International Journal of Scientific Research ...
A diagnostic medical sonographer could be answering the question "Is it a boy or a girl?" as well as a host of other life-changing medical questions with the help of ultrasound technology.
The multiyear agreement calls for Chicago-based GE HealthCare provide AI-enabled diagnostic imaging technology to Nuffield ...
Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), a developer and investment partner in advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback